The prognostic significance of p63 and Ki-67 expression in myoepithelial carcinoma

Head and Neck Oncology

Volumn 4, Issue 1, 2012, Pages

  Jiang, You Hua ^a   Cheng, Bo ^a   Ge, Ming Hua ^a   Zhang, Gu ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Ki 67; Myoepithelial carcinoma; p63; Prognosis

Indexed keywords

KI 67 ANTIGEN; PROTEIN P63; TUMOR MARKER; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MYOEPITHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL RATE; SURVIVAL TIME; BIOSYNTHESIS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MYOEPITHELIOMA; PROGNOSIS; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84862780387     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-4-9     Document Type: Article

References (24)

1. Myoepithelioma of minor salivary gland origin. Light and electron microscopical study. Stromeyer FW, Haggitt RC, Nelson JF, Hardman JM, Arch Pathol 1975 99 242 245 48374
2. Salivary gland malignant myoepithelioma: a clinicopathologic and immunohistochemical study of ten cases. Nagao T, Sugano I, Ishida Y, Tajima Y, Matsuzaki O, Konno A, Kondo Y, Nagao K, Cancer 1998 83 1292 1299 10.1002/(SICI)1097-0142(19981001)83:7<1292::AID-CNCR4>3.0.CO;2-L 9762928 (Pubitemid 28460078)
3. Malignant myoepithelioma of the palate: a case report with review of the clinicopathological characteristics. Acikalin MF, Pasaoglu O, Cakli H, Gürbüz K, Canaz F, Yonsei Med J 2009 50 848 851 10.3349/ymj.2009.50.6. 848 20046429
4. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast - a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells. Hungermann D, Buerger H, Oehlschlegel C, Herbst H, Boecker W, BMC Cancer 2005 5 92 10.1186/1471-2407-5-92 16050957 (Pubitemid 41461043)
5. DNA content and proliferative activity of myoepitheliomas. El-Naggar A, Batsakis JG, Luna MA, Goepfert H, Tortoledo ME, J Laryngol Otol 1989 103 1192 1197 2559135 (Pubitemid 20020339)
6. Primary malignant myoepithelioma of the left maxillary sinus: a case report. Zhou SH, Ruan LX, Gong L, Wang SQ, J Int Med Res 2008 36 362 365 18380949 (Pubitemid 351516621)
7. Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 51 cases in a tertiary cancer center. Kane SV, Bagwan IN, Arch Otolaryngol Head Neck Surg 2010 136 702 712 10.1001/archoto.2010.104 20644067
8. p63: Molecular complexity in development and cancer. Westfall MD, Pietenpol JA, Carcinogenesis 2004 25 857 864 10.1093/carcin/bgh148 15033906 (Pubitemid 38886071)
9. Diagnostic and prognostic impact of p63 immunoreactivity in renal malignancies. Tuna B, Unlu M, Aslan G, Secil M, Yorukoglu K, Anal Quant Cytol Histol 2009 31 118 122 19402389
10. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma. Takahashi Y, Noguchi T, Takeno S, Kimura Y, Okubo M, Kawahara K, Oncol Rep 2006 15 323 328 16391849
11. Effect of p63 expression on survival in oral squamous cell carcinoma. LoMuzio L, Campisi G, Farina A, Rubini C, Pastore L, Giannone N, Colella G, Leonardi R, Carinci F, Cancer Invest 2007 25 466 469
12. Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis. Ramer N, Wu H, Sabo E, Ramer Y, Emanuel P, Orta L, Burstein DE, Cancer 2010 116 77 83 19877114
13. Expression of p63 is the sole independent marker of aggressiveness in localized (stage I-II) Merkel cell carcinomas. Asioli S, Righi A, de Biase D, Morandi L, Caliendo V, Picciotto F, Macrip G, Maletta F, di Cantogno LV, Chiusa L, Eusebi V, Bussolati G, Mod Pathol 2011 24 1451 1461 10.1038/modpathol.2011. 100 21765392
14. Vascular endothelial growth factor (VEGF) expression correlates with p53 and ki-67 expressions in tongue squamous cell carcinoma. Mineta H, Miura K, Ogino T, Takebayashi S, Misawa K, Ueda Y, Anticancer Res 2002 22 1039 1044 12168898 (Pubitemid 34836148)
15. Expression of Ki67 and P53 in primary squamous cell carcinoma of the larynx. Ashraf MJ, Maghbul M, Azarpira N, Khademi B, Indian J Pathol Microbiol 2010 53 661 665 10.4103/0377-4929.72019 21045388
16. Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis. Tang QL, Fan S, Li HG, Chen WL, Shen XM, Yuan XP, Chang SH, Song Y, Oral Oncol 2011 47 365 370 10.1016/j.oraloncology.2011.02. 022 21439895
17. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland. Okabe M, Inagaki H, Murase T, Inoue M, Nagai N, Eimoto T, Mod Pathol 2001 14 1008 1014 10.1038/modpathol. 3880426 11598171 (Pubitemid 32976789)
18. Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective study. Schmilovitz-Weiss H, Tobar A, Halpern M, Levy I, Shabtai E, Ben-Ari Z, Diagn Pathol 2011 6 121 10.1186/1746-1596-6-121 22151825
19. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma. Faratian D, Munro A, Twelves C, Bartlett JM, Histopathology 2009 54 254 257 10.1111/j.1365-2559.2008.03191.x 19207951
20. 18F-FDG PET activity with expressions of survivin, Ki67, and CD34 in non-small-cell lung cancer. Han B, Lin S, Yu LJ, Wang RZ, Wang YY, Nucl Med Commun 2009 30 831 837 10.1097/MNM.0b013e32832dcfc4 19734817
21. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma. Perisanidis C, Perisanidis B, Wrba F, Brandstetter A, El Gazzar S, Papadogeorgakis N, Seemann R, Ewers R, Kyzas PA, Filipits M, J Oral Pathol Med 2012 41 40 46 10.1111/j.1600-0714.2011.01071.x 21883486
22. Myoepithelial carcinoma of soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases. Gleason BC, Fletcher CD, Am J Surg Pathol 2007 31 1813 1824 10.1097/PAS.0b013e31805f6775 18043035 (Pubitemid 350175808)
23. Expression of cell cycle-regulatory proteins, MIB-1, p16, p53, and p63, in squamous cell carcinoma of conjunctiva:not associated with human papillomavirus infection. Jung SM, Lin HC, Chu PH, Wu HH, Shiu TF, Huang SL, Lai CH, Virchows Arch 2006 448 301 305 10.1007/s00428-005-0104-2 16328355 (Pubitemid 43357646)
24. Are biomarkers correlated with recurrence patterns in patients with resectable gastric adenocarcinoma. Li GC, Zhang Z, Ma XJ, Gu WL, Wang YN, Li J, Mol Biol Rep 2012 39 399 405 10.1007/s11033-011-0751-0 21559839